Could carbon monoxide and bilirubin be friends as well as foes of the body?

References

• Sjöstrand T. Endogenous production of carbon monoxide in man under normal and pathophysiological conditions. Scand J Clin Lab Invest 1949;1:201–14.
   Web of Science ®Google Scholar
• Sjöstrand T. The formation of carbon monoxide by the decomposition of hemoglobin in vivo. Acta Physiol Scand 1952;26:338–44.
   PubMedGoogle Scholar
• Ryter SW, Alam J, Choi AMK. Heme oxygenase-1/carbon monoxide: From basic science to therapeutic applications. Physiol Rev 2006;86:583–650.
   PubMed Web of Science ®Google Scholar
• Foresti R, Green CJ, Motterlini R. Generation of bile pigments by haem oxygenase: a refined cellular strategy in response to stressful insults. Biochem Soc Symp 2004;71:177–92.
   PubMedGoogle Scholar
• Otterbein LE. Carbon monoxide: innovative anti-inflammatory properties of an age-old gas molecule. Antioxid Redox Signal 2002;4:309–19.
   PubMed Web of Science ®Google Scholar
• Motterlini R, Mann BE, Foresti R. Therapeutic applications of carbon monoxide-releasing molecules. Expert Opin Investig Drugs 2005;14:1305–18.
   PubMed Web of Science ®Google Scholar
• Öllinger R, Wang HJ, Yamashita K, Wegiel B, Thomas M, Margreiter R, Bach FH. Therapeutic applications of bilirubin and biliverdin in transplantation. Antioxid Redox Signal 2007;9:2175–85.
   PubMed Web of Science ®Google Scholar
• Foresti B, Bani-Hani MG, Motterlini R. Use of carbon monoxide as a therapeutic agent: promises and challenges. Intensive Care Med 2008;34:649–58.
   PubMed Web of Science ®Google Scholar
• Stocker R, Ames BN. Potential role of conjugated bilirubin and copper in the metabolism of lipid peroxides in bile. Proc Natl Acad Sci USA 1987;84:8130–4.
   PubMed Web of Science ®Google Scholar
• Sedlak TW, Snyder SH. Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics 2004;113:1776–82.
   PubMed Web of Science ®Google Scholar
• Gorman D, Drewry A, Huang YL, Sames C. The clinical toxicology of carbon monoxide. Toxicology 2003;187:25–38.
   PubMed Web of Science ®Google Scholar
• Scharte M, von Ostrowski TA, Daudel F, Freise H, Van Aken H, Bone HG. Endogenous carbon monoxide production correlates weakly with severity of acute illness. Eur J Anaesthesiol 2006;23:117–22.
   PubMed Web of Science ®Google Scholar
• Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, Davis RJ, Flavell RA, Choi AM. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nature Med 2000;6:422–8.
   PubMed Web of Science ®Google Scholar
• Tsui TY, Obed A, Siu YT, Yet SF, Prantl L, Schlitt HJ, Fan ST. Carbon monoxide inhalation rescues mice from fulminant hepatitis through improving hepatic energy metabolism. Shock 2007;27:165–71.
   PubMed Web of Science ®Google Scholar
• Mayr FB, Spiel A, Leitner J, Marsik C, Germann P, Ullrich R, Wagner O, Jilma B. Effects of carbon monoxide inhalation during experimental endotoxemia in humans. Am J Respir Crit Care Med 2005;171:354–60.
   PubMed Web of Science ®Google Scholar
• Sarady JK, Zuckerbraun BS, Bilban M, Wagner O, Usheva A, Liu F, Ifedigbo E, Zamora R, Choi AM, Otterbein LE. Carbon monoxide protection against endotoxic shock involves reciprocal effects on iNOS in the lung and liver. FASEB J 2004;18:854–6.
   PubMed Web of Science ®Google Scholar
• Johnson FK, Johnson RA. Carbon monoxide promotes endotheliumdependent constriction of isolated gracilis muscle arterioles. Am J Physiol Regul Integr Comp Physiol 2003;285:R536–41.
   PubMed Web of Science ®Google Scholar
• Oberle S, Abate A, Grosser N, Hemmerle A, Vreman HJ, Dennery PA, Schneider HT, Stalleicken D, Schröder H. Endothelial protection by pentaerithrityl trinitrate: bilirubin and carbon monoxide as possible mediators. Exp Biol Med 2003;228:529–34.
   PubMed Web of Science ®Google Scholar
• Serhan CN, Takano T, Maddox JF. Aspirin-triggered 15-epilipoxin A4 and stable analogs on lipoxin A4 are potent inhibitors of acute inflammation: receptors and pathways. Adv Exp Med Biol 1999;447:133–49.
   PubMedGoogle Scholar
• Weid P-Y, Hollenberg MD, Fiorucci S, Wallace JL. Aspirin-triggered, cyclooxygenase-2-dependent lipoxin synthesis modulates vascular tone. Circulation 2004;110:1320–5.
   PubMedGoogle Scholar
• Nascimento-Silva V, Arruda MA, Barja-Fidalgo C, Villela CG, Fierro IM. Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells. Am J Physiol Cell Physiol 2005;289:C557–63.
   Web of Science ®Google Scholar
• Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 1994;40:18–23.
   PubMed Web of Science ®Google Scholar
• Breimer LH, Spyropolous KA, Winder AF, Mikhailidis DP, Hamilton G. Is bilirubin protective against coronary artery disease? Clin Chem 1994;40:1987–8.
   PubMedGoogle Scholar
• Breimer LH, Wannamethee G, Ebrahim S, Shaper, AG. (1995). Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem 1995;41:1504–8.
   PubMed Web of Science ®Google Scholar
• Breimer LH, Mikhailidis DP. Bilirubin and peripheral arterial disease: 15 years later. Expert Opin Ther Targets 2009;13:139–40.
   PubMed Web of Science ®Google Scholar
• Breimer LH. Bilirubin and cardiovascular disease. J Insur Med in press.
   Google Scholar
• Fulks M, Stout RL, Dolan VF. Mortality associated with bilirubin levels in insurance applicants. J Insur Med 2009;41:49–53.
   PubMedGoogle Scholar
• Adin CA, Croker BP, Agarwal A. Protective effects of exogenous bilirubin on ischemia-reperfusion injury in the isolated, perfused rat kidney. Am J Physiol Renal Physiol 2005;288:F778–84.
   PubMed Web of Science ®Google Scholar
• Kirkby K, Baylis C, Agarwal A, Croker B, Archer L, Adin C. Intravenous bilirubin provides incomplete protection against renal ischemia-reperfusion injury in vivo. Am J Physiol Renal Physiol 2007;292:888–94.
   Google Scholar
• Ceran C, Sonmez K, Turkyllmaz Z, Demirogullarl B, Dursun A, Duzgun E, Basaklar AC, and Kale N. Effect of bilirubin in ischemia/reperfusion injury on rat small intestine. J Pediatr Surg 2001;36:1764–7.
   PubMedGoogle Scholar
• Demirogullari B, Ekingen G, Guz G, Bukan N, Edam O, Ozen IO, Memis L, Sert S. A comparative study of the effects of hemin and bilirubin on bilateral renal ischemia reperfusion injury. Nephron Exp Nephrol 2006;103:e1–5.
   Google Scholar
• Attuwaybi BO, Kozar RA, Moore-Olufemi SD, Sato N, Hassoun HT, Weisbrodt NW, Moore FA. Heme oxygenase-1 induction by hemin protects against gut ischemia/reperfusion injury. J Surg Res 2004;118:53–7.
   PubMed Web of Science ®Google Scholar
• Oberle S, Abate A, Grosser N, Hemmerle A, Vreman HJ, Dennery PA, Schneider HT, Stalleicken D, SchrÖder H. Endothelial protection by pentaerithrityl trinitrate: bilirubin and carbon monoxide as possible mediators. Exp Biol Med 2003;228:529–34.
   PubMed Web of Science ®Google Scholar
• Sayed N, Baskaran P, Ma X, Akker F, Beuve A. Desensitization of soluble guanyl cyclase, the NO receptor, by Snitrosylation. Proc Natl Acad Sci USA 2007;104:12312–7.
   PubMedGoogle Scholar
• Chang F-J, Lemme S, Sun Q, Sunhara RK, Beuve A. Nitric oxide-dependent allosteric inhibitiory role of a second nucleotide binding site in soluble guanylyl cyclase. J Biol Chem 2005;280:11513–9.
   PubMedGoogle Scholar
• Grosser N, Hemmerle A, Berndt G, Erdmann K, Hinkelmann U, Schurgerc S, Wijayanti N, Immenschuh S, Schroder H. The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells. Free Radic Biol Med 2004;37:2064–71.
   PubMed Web of Science ®Google Scholar
• Gueler F, Park J-K, Rong S, Kirsch T, Lindschau C, Zheung W, Elger M, Fiebeler A, Fliser D, Luft FC, Haller H. Statins attenuate ischemia-reperfusion injury by inducing heme oxygenase-1 in infiltrating macrophages. Am J Pathol 2007;170:1192–9.
   PubMed Web of Science ®Google Scholar
• Muchova L, Wong RJ, Hsu M, Morioka I, Vitek L, Zelenka J, Schr¨der H, Stevenson DK. Statin treatment increases formation of carbon monoxide and bilirubin in mice: a novel mechanism of in vivo antioxidant protection. Can J Physiol Pharmacol 2007;85:800–10.
   PubMed Web of Science ®Google Scholar
• Desbuards N, Rochefort GY, Schlecht D, Machet MC, Halimi JM, Eder V, Hyvelin JM, Antier D. Heme oxygenase-1 inducer hemin prevents vascular thrombosis. Thromb Hae-most 2007;98:614–20.
   PubMedGoogle Scholar
• Wang H, Lee SS, Dell'Agnello C, Tchipashvili V, d'Avila JC, Czismadia E, Chin BY, and Bach FH. Bilirubin can induce tolerance to islet allografts. Endocrinology 2006;147:762–8.
   PubMedGoogle Scholar
• Sato K, Balla J, Otterbein L, Smith RN, Brouard S, Lin Y, Csizmadia E, Sevigny J, Robson SC, Vercellotti G, Choi AM, Bach FH, Soares MP. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 2001;166:4185–94.
   PubMedGoogle Scholar
• Marazioti A, Baskaran P, Beuve A, Romao C, Pyriochou A, Papapetropoulos A. Effects of carbon monoxide-releasing molecules on cGMP levels and soluble guanylate cyclase activity. BMC Pharmacology 2009;9(Suppl. 1):P45 DOI:10.1186/1471-2210-9-S1-P45.
   Google Scholar
• Chen B, Guo L, Fan C, Bolisetty S, Joseph R, Wright MM, Agarwal A, George JF. Carbon monoxide rescues heme oxygenase-1-deficient mice from arterial thrombosis in allogeneic aortic transplantation. Am J Pathol 2009;175:422–9.
   PubMedGoogle Scholar
• Nielsen VG, Kirklin JK, George JF. Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in human plasma. Blood Coagul Fibrinolysis 2009;20:377–80.
   PubMedGoogle Scholar
• Chlopicki S, Olszanecki R, Marcinkiewicz E, Lomnicka M, Motterlini R. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase. Cardiovasc Res 2006;71:393–401.
   PubMedGoogle Scholar
• Motterlini R, Sawle P, Hammad J, Bains S, Alberto R, Foresti R, Green CJ. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule. FASEB J 2005;19:284–6.
   PubMed Web of Science ®Google Scholar
• Sandouka A, Fuller BJ, Mann BE, Green CJ, Foresti R, Motterlini R. Treatment with carbon monoxide-releasing molecules (CO-RMs) during cold storage improves renal function at reperfusion. Kidney Int 2006;69:239–47.
   PubMedGoogle Scholar
• Varadi H, Lekli I, Juhasz B, Bacskay I, Szabo G, Gesztelyi R, Szendrei L, Varga E, Bak I, Foresti R, Motterlini R, Tosaki A. Beneficial effects of carbon monoxide-releasing molecules on post-ischemic myocardial recovery. Life Sci 2007;80:1619–26.
   PubMed Web of Science ®Google Scholar
• Ramshorst J, Bax JJ, Beeres SLMA, Dibbets-Schneider P, Roes SD, Stokkel MPM, de Roos A, Fibbe WE, Zwaginga JJ, Boersma E, Schalij MJ, Atsma DE. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. JAMA 2009;301:1997–2004.
   PubMedGoogle Scholar